New Zealand markets closed

Progenity, Inc. (PROG)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
2.2950-0.4250 (-15.62%)
As of 03:00PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close2.7200
Open2.6800
Bid2.3300 x 1100
Ask2.3400 x 900
Day's range2.2700 - 2.7100
52-week range0.6570 - 7.8600
Volume36,068,097
Avg. volume81,786,845
Market cap375.806M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)-3.4440
Earnings date10 Nov 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est3.00
  • GlobeNewswire

    Progenity Announces New Patent for Single-Molecule Detection Technology

    SAN DIEGO, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the fields of gastrointestinal health and oral biotherapeutics, today announced a new patent related to its single-molecule detection platform under development. The USPTO has issued U.S. Patent No. 11,186,863 entitled, “Methods, Systems, and Compositions for Counting Nucleic Acid Molecules.” The issued claims cover methods for capturing, amplifying, and imaging single copies of tar

  • Motley Fool

    Why Shares of Progenity Are Down More Than 11% on Wednesday

    Progenity (NASDAQ: PROG), a biotech company and a meme stock favorite, saw its shares decline more than 11% on Wednesday. Overall, Progenity stock is down more than 47% this year. The markets don't like uncertainty, and that's one reason Progenity has trended downward.

  • GlobeNewswire

    Progenity Strengthens its Liquidity Position

    Company received more than $44 million in warrant exercises since August 2021. Current liquidity position provides runway to achieve critical research and development milestones through 2022. SAN DIEGO, Nov. 23, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the fields of gastrointestinal health and oral biotherapeutics, today provided an update on its strengthened liquidity position. “Over the last several months, we made great strides in optimizi